- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Kabra Drugs Limited has announced a change in its key managerial personnel. The Board of Directors has approved the appointment of Mr. T. Pavanasam as the new Chief Financial Officer, effective immediately. Concurrently, Mr. Bangalore Venkatakrishnappa Ananth Kumar has resigned from the position of Chief Financial Officer. Mr. Pavanasam brings over 15 years of experience in finance, taxation, and related legal areas across various industries, ensuring continued financial leadership for the company.